Canopy Growth Corp (TSE:WEED – Get Free Report)’s stock price hit a new 52-week low during trading on Monday. The company traded as low as C$0.93 and last traded at C$0.94, with a volume of 230,265 shares changing hands. The stock had previously closed at C$0.95.
Canopy Growth Price Performance
The company’s 50 day moving average is C$1.26 and its 200 day moving average is C$1.41. The stock has a market capitalization of C$397.66 million, a price-to-earnings ratio of -1.40, a price-to-earnings-growth ratio of -0.01 and a beta of 2.41. The company has a current ratio of 3.04, a quick ratio of 2.32 and a debt-to-equity ratio of 40.27.
Canopy Growth (TSE:WEED – Get Free Report) last announced its earnings results on Friday, August 7th. The company reported C($0.03) earnings per share for the quarter. The business had revenue of C$81.17 million for the quarter. Canopy Growth had a negative return on equity of 29.85% and a negative net margin of 73.95%. Research analysts anticipate that Canopy Growth Corp will post -0.69 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, Director David Angelo Lazzarato sold 22,380 shares of Canopy Growth stock in a transaction that occurred on Monday, September 28th. The stock was sold at an average price of C$1.29, for a total transaction of C$28,870.20. Following the completion of the transaction, the director directly owned 108,237 shares in the company, valued at C$139,625.73. The trade was a 17.13% decrease in their position. In the last ninety days, insiders have sold 43,492 shares of company stock worth $56,105. Company insiders own 0.21% of the company’s stock.
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Further Reading
- Five stocks we like better than Canopy Growth
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
